# US 2017/0319750 A1 · Composite matrices designed for enhanced bone repair

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0319750 A1
- Document ID: US20170319750A1
- Status: Published application
- Kind: A1
- Application number: 15/589,005
- Filed: 2017-05-08
- Published: 2017-11-09
- Earliest claimed: 2016-05-09
- Assignees: Bioventus, LLC; CollPlant Ltd.
- Applicants: Bioventus, LLC; CollPlant Ltd.
- Inventors: Orly Grinberg; Nadav Orr; Howard Seeherman; Oded Shoseyov; Eric Vanderploeg; Christopher Wilson; John Wozney
- Web page: https://patentgrep.com/patent/US20170319750A1

## CPC

- A61L 27/48: with macromolecular fillers
- A61K 38/1875: {Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor}
- A61L 27/12: Phosphorus-containing materials, e.g. apatite
- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/24: Collagen
- A61L 27/34: Macromolecular materials
- A61L 27/46: with phosphorus-containing inorganic fillers
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61L 27/58: Materials at least partially resorbable by the body
- B29C 39/003: {characterised by the choice of material}
- B29C 39/025: {for making multilayered articles}
- A61F 2002/2835: {Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material}
- A61L 2300/252: Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L 2300/414: Growth factors
- A61L 2420/02: Methods for coating medical devices
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- B29K 2089/00: Use of proteins, e.g. casein, gelatine or derivatives thereof, as moulding material
- B29K 2105/16: Fillers
- B29K 2509/02: Ceramics
- B29K 2995/006: Bio-degradable, e.g. bioabsorbable, bioresorbable or bioerodible
- B29L 2031/7532: {Artificial members, protheses}
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- B29C: SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING (making preforms B29B11/00; making laminated products by combining previously unconnected layers which become one product whose layers will remain together B32B37/00 - B32B41/00)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- B29K: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR {MOULDS, } REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29L: INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES

## Abstract

Osteoconductive synthetic bone grafts are provided in which porous ceramic granules are embedded in a biocompatible matrix material. The grafts, which may also include one or more of a coating, a reinforcing bio-absorbable mesh, and an osteoinductive protein or peptide, are generally porous and may incorporate fenestrations.

## Claims

### Claim 1

A biocompatible implant, comprising:
a matrix comprising cross-linked rhCollagen derived from a plant, said matrix having a density of 10-20 mg rhCollagen per cubic centimeter of the matrix and including a plurality of interconnected pores having a mean cross-sectional dimension between 100 and 300 microns;
a plurality of porous, calcium ceramic granules embedded within the matrix at a ratio of 150-310 milligrams of granules per cubic centimeter of matrix;
a bioresorbable polymer mesh within said matrix; and
a coating comprising rhCollagen and at least partially covering said matrix.

### Claim 2 (depends on 1)

The implant of claim 1, wherein said matrix includes a plurality of fenestrations.

### Claim 3 (depends on 2)

The implant of claim 2, wherein each fenestration of the plurality of fenestrations has a mean cross sectional dimension of 1-2 mm.

### Claim 4 (depends on 3)

The implant of claim 3, wherein at least some of said plurality of fenestrations extend through a thickness of said matrix.

### Claim 5 (depends on 1)

The implant of claim 1, further comprising a bone morphogenetic protein.

### Claim 6 (depends on 5)

The implant of claim 5, wherein said bone morphogenetic protein is associated with said granules.

### Claim 7 (depends on 1)

The implant of claim 1, wherein said granules have an average size within the range of 425 to 800 microns.

### Claim 8 (depends on 1)

The implant of claim 1, wherein said mesh comprises a plurality of resorbable polymer fibers arranged in a yarn, and said yarn is fabricated into said mesh.

### Claim 9 (depends on 8)

The implant of claim 8, wherein said mesh is characterized by openings with an average size of 1-2 millimeters.

### Claim 10 (depends on 9)

The implant of claim 9, wherein said resorbable polymer comprises PGLA.

### Claim 11 (depends on 1)

The implant of claim 1, wherein said calcium ceramic granules comprise calcium deficit hydroxyapatite.

### Claim 12

A method of making a biocompatible implant, comprising the steps of:
forming a solution comprising cross-linked rhCollagen and a plurality of calcium ceramic granules;
transferring at least a portion of said solution within a mold to form a first slurry layer;
placing a bioresorbable polymer mesh onto said first slurry layer;
transferring at least a portion of said solution within the mold to form a second slurry layer and a preform comprising the first slurry layer, the bioresorbable polymer mesh, and the second slurry layer;
lyophilizing the preform;
contacting the preform with a coating material comprising rhCollagen, thereby at least partially coating the preform; and
lyophilizing the at least partially coated preform.

### Claim 13 (depends on 12)

The method of claim 12, wherein the mold includes a plurality of protrusions.

### Claim 14 (depends on 12)

The method of claim 12, further comprising the step of cross-linking the preform before said step of contacting the preform with a coating material.

### Claim 15 (depends on 14)

The method of claim 14, wherein said step of cross-linking comprises soaking said preform with 1-[3-(Dimethylamino) propyl]-3-ethylcarbodiimide.

### Claim 16 (depends on 1)

A kit comprising the implant of claim 1.

### Claim 17 (depends on 16)

The kit of claim 16, further comprising a container of lyophilized osteoinductive protein.

### Claim 18

A method of treating a patient, comprising the steps of:
contacting a bony tissue of the patient with a biocompatible implant, said implant comprising:
a matrix comprising cross-linked rhCollagen derived from a plant, said matrix having a density of 10-20 mg rhCollagen per cubic centimeter of matrix and including a plurality of interconnected pores having a mean cross-sectional dimension between 100 and 300 microns;
a plurality of porous, calcium ceramic granules embedded within the matrix at a ratio of 150-250 mg granules per cubic centimeter of matrix;
a bioresorbable polymer mesh within said matrix;
a coating comprising rhCollagen and at least partially covering said matrix; and
and an osteoinductive protein associated with the plurality of calcium ceramic granules.

### Claim 19 (depends on 18)

The method of claim 18, wherein the protein-loaded biocompatible implant includes a plurality of fenestrations.

### Claim 20 (depends on 19)

The method of claim 19, wherein each of the plurality of fenestrations has a mean cross sectional dimension of between 1-2 mm.

### Claim 21 (depends on 18)

The implant of claim 18, wherein said granules have an average size within the range of 425 to 800 microns.

### Claim 22 (depends on 18)

The implant of claim 18, wherein said mesh comprises poly-glycolide-co-lactide.

### Claim 23 (depends on 18)

The implant of claim 18, wherein said calcium ceramic granules comprise calcium deficit hydroxyapatite.
